Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C infection and autoimmunity

A L Eddleston1

  • 1Institute of Liver Studies, King's College School of Medicine and Dentistry, London, UK.

Journal of Hepatology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The development of a more equitable approach to resource allocation and manpower planning for undergraduate teaching in a UK medical school.

Medical education·2001
Same author

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Journal of hepatology·1999
Same author

Service increment for teaching (SIFT): a review of its origins, development and current role in supporting undergraduate medical education in England and Wales.

Medical education·1999
Same author

Hepatitis B and health-care workers.

Lancet (London, England)·1997
Same author

The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis.

Journal of hepatology·1995
Same author

Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.

Hepatology (Baltimore, Md.)·1995

Hepatitis C virus (HCV) infection is associated with autoimmune liver diseases, particularly in Southern Europe. Distinguishing between HCV and autoimmune hepatitis is crucial for effective treatment, as therapies can conflict.

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection has been linked to autoimmune liver diseases and other autoimmune conditions.
  • Early diagnostic tests for HCV antibodies were non-specific, leading to confusion with autoimmune hepatitis.
  • Geographic variations in Europe show higher associations between HCV and autoimmune liver diseases in the south compared to the north.

Purpose of the Study:

  • To clarify the true associations between HCV infection and autoimmune liver diseases.
  • To investigate specific subgroups of autoimmune hepatitis, particularly those associated with liver/kidney microsomal antigen antibodies (cytochrome P450 2D6).
  • To explore the clinical implications and treatment challenges when HCV infection co-exists with autoimmune hepatitis.

Main Methods:

Related Experiment Videos

  • Analysis of European survey data on HCV and autoimmune liver disease prevalence.
  • Subgroup analysis of autoimmune hepatitis patients, focusing on those with liver/kidney microsomal antigen antibodies.
  • Review of clinical reports and treatment outcomes for co-infected patients.

Main Results:

  • True associations between HCV and autoimmune liver diseases exist, with higher prevalence in Southern Europe.
  • Distinct subgroups of autoimmune hepatitis were identified, including one driven by HCV infection in older patients.
  • HCV infection shows a lower incidence of periportal hepatitis compared to other viral hepatitis types.
  • HCV infection is a significant driver for conditions like cryoglobulinemia, responding to interferon treatment.

Conclusions:

  • Hepatitis C virus infection is genuinely associated with autoimmune liver diseases, with significant geographic variation.
  • Differentiating between HCV infection and co-existing autoimmune hepatitis is clinically important due to conflicting treatment strategies.
  • Interferon therapy for HCV can trigger autoimmune hepatitis relapse, while steroids for autoimmune hepatitis may promote HCV replication.